Document is current

Any future updates will be listed below

Engineered CAR-NK Cells for Cancer Immunotherapy: Lentiviral-Based CAR Transduction of NK-92 Cells

Crossref DOI link: https://doi.org/10.1007/978-1-0716-4558-1_19

Published Online: 2025-05-23

Published Print: 2025

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark